Redeye makes downward estimate revisions on the back of I-Tech’s Q4 figures, as sales were slightly postponed, and costs grew more than expected. The underlying customer pipeline continues to progress, most recently by signing a contract with Akzo in South Korea. Moreover, I-Tech posted news regarding its strategic direction which balances nicely between dividends/investments and potential M&A.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

I-Tech - Q4 Review – Underlying Progress

© Modular Finance, source Nordic Press Releases